{"id":1836,"date":"2025-02-17T09:00:15","date_gmt":"2025-02-17T09:00:15","guid":{"rendered":"https:\/\/dita.md\/pharmacovigilance\/"},"modified":"2025-02-24T15:54:52","modified_gmt":"2025-02-24T15:54:52","slug":"pharmacovigilance","status":"publish","type":"page","link":"https:\/\/dita.md\/en\/pharmacovigilance\/","title":{"rendered":"Pharmacovigilance"},"content":{"rendered":"            <section class='hero-big'>\n                                                    <img decoding=\"async\" class=\"object-cover\" src=\"https:\/\/dita.md\/wp-content\/uploads\/2025\/02\/knapp-e1739431951125.jpg\" alt=\"hero image\">\n                        <div class=\"wrap\">\n                                <div class='box'>\n                                            <h1> Servicii de Farmacovigilen\u021b\u0103 \u2013 Siguran\u021b\u0103 \u0219i Monitorizare Continu\u0103<\/h1>\n                                        \n                                    <\/div>\n            <\/div>\n        <\/section>\n    \n\n            <section class='page-section pharmacovigilance-title-section'>\n            <div class=\"wrap\">\n                <p>Monitoriz\u0103m siguran\u021ba produselor farmaceutice pentru a asigura conformitatea \u0219i pentru a r\u0103spunde prompt la orice reac\u021bie advers\u0103.<\/p>\n            <\/div>\n        <\/section>\n    \n\n            <section class='page-section'>\n            <div class=\"wrap\">\n                <div class=\"section-top-box\">\n                                            <h2>Raportare reac\u021bii adverse pentru consumatori<\/h2>\n                                                                <p>Organiza\u021bia Mondial\u0103 a S\u0103n\u0103t\u0103\u021bii (OMS) define\u0219te farmacovigilen\u021ba ca \u0219tiin\u021ba \u0219i activitatea privind depistarea, evaluarea \u0219i prevenirea reac\u021biilor adverse sau a oric\u0103ror alte probleme de siguran\u021ba privind medicamentele.<\/p>\n                                    <\/div>  \n                <div class=\"pharmacovigilance-content\">\n                                            <div class=\"box-img\">\n                            <img loading=\"lazy\" decoding=\"async\" width=\"765\" height=\"500\" src=\"https:\/\/dita.md\/wp-content\/uploads\/2025\/01\/25182803_7052728-1.png\" class=\"attachment-full size-full\" alt=\"\" srcset=\"https:\/\/dita.md\/wp-content\/uploads\/2025\/01\/25182803_7052728-1.png 765w, https:\/\/dita.md\/wp-content\/uploads\/2025\/01\/25182803_7052728-1-300x196.png 300w\" sizes=\"auto, (max-width: 765px) 100vw, 765px\" \/>                        <\/div>\n                                                                <b class='list-title'>Siguran\u021ba pacien\u021bilor este prioritatea noastr\u0103. Dac\u0103 dori\u021bi s\u0103 raporta\u021bi o reac\u021bie advers\u0103, v\u0103 rug\u0103m s\u0103 ne furniza\u021bi urm\u0103toarele informa\u021bii:<\/b>\n                                        <ul class='ordered-list'>\n                                                    <li>Date despre persoana care manifest\u0103 RA (nume, prenume, v\u00e2rst\u0103, sex, greutate).<\/li>\n                                                    <li>Descrierea reac\u021biei adverse (momentul apari\u021biei, durata, simptomele manifestate, m\u0103surile luate).<\/li>\n                                                    <li>Detalii despre medicamentul care a provocat RA (denumirea, doza, seria, form\u0103 farmaceutic\u0103, substan\u021ba activ\u0103, produc\u0103tor, indica\u021bii de utilizare).<\/li>\n                                                    <li>Informa\u021bii despre raportor (nume, prenume, date de contact).<\/li>\n                                            <\/ul>     \n                                            <div class=\"desc\"><p>\ud83d\udce9 <strong>Trimite\u021bi raportul la:<\/strong> <strong><a rel=\"noopener\">farmacovigilenta@dita.md<\/a><\/strong><br \/>\n\ud83d\udcde <strong>Raporta\u021bi telefonic (24\/7):<\/strong> <strong>+373 22 527 474<\/strong><\/p>\n<\/div>\n                                    <\/div>                          \n            <\/div>\n        <\/section>\n    \n\n            <section class='page-section'>\n            <div class=\"wrap\">\n                <div class=\"section-top-box\">\n                                            <h2>Raporteaz\u0103 o reac\u021bie advers\u0103<\/h2>\n                                                                <p> Raportarea prompt\u0103 ne ajut\u0103 s\u0103 asigur\u0103m un nivel ridicat de siguran\u021b\u0103 pentru to\u021bi pacien\u021bii.  V\u0103 aten\u021bion\u0103m c\u0103 toate informa\u021biile vor fi utilizate \u00een mod confiden\u021bial (\u00een conformitate cu Legea nr. 133 din 08-07-2011 privind protec\u021bia datelor cu caracter personal) \u0219i exclusiv \u00een scopul Farmacovigilen\u021bei. \r\nDup\u0103 prelucrarea informa\u021biilor primite, speciali\u0219ii no\u0219tri v\u0103 vor contacta. <\/p>\n                                                                                        <a target=\"_blank\" href=\"http:\/\/dita.md\/contacte\/\" class=\"btn blue\">\n                            Raporteaz\u0103 AICI                        <\/a>\n                                    <\/div>                     \n            <\/div>\n        <\/section>\n    \n\n            <section class='page-section page-section-blue pharmacovigilance-content-section'>\n        <div class=\"wrap\">\n            <div class=\"section-top-box\">\n                                    <h2>Parteneriat pentru Siguran\u021b\u0103 \u2013 Servicii Profesionale de Farmacovigilen\u021b\u0103<\/h2>\n                                                    <p>Dita Estfarm este un furnizor autorizat de servicii de farmacovigilen\u021b\u0103 (FV) \u00een Republica Moldova, asigur\u00e2nd monitorizarea eficacit\u0103\u021bii \u0219i siguran\u021bei medicamentelor. Oferim o gam\u0103 complet\u0103 de servicii, inclusiv depistarea, evaluarea \u0219i prevenirea reac\u021biilor adverse, precum \u0219i gestionarea oric\u0103ror probleme de siguran\u021b\u0103 asociate medicamentelor.\r\n\r\nDispunem de echipamente tehnice moderne \u0219i de un personal calificat, preg\u0103tit s\u0103 desf\u0103\u0219oare aceste activit\u0103\u021bi la cele mai \u00eenalte standarde de calitate, contribuind astfel la protec\u021bia pacien\u021bilor \u0219i la siguran\u021ba utiliz\u0103rii medicamentelor.<\/p>\n                            <\/div>  \n            <div class=\"pharmacovigilance-content\">\n                                    <div class=\"box-img\">\n                        <img loading=\"lazy\" decoding=\"async\" width=\"547\" height=\"500\" src=\"https:\/\/dita.md\/wp-content\/uploads\/2025\/01\/13795570_5366526-1.png\" class=\"attachment-full size-full\" alt=\"\" srcset=\"https:\/\/dita.md\/wp-content\/uploads\/2025\/01\/13795570_5366526-1.png 547w, https:\/\/dita.md\/wp-content\/uploads\/2025\/01\/13795570_5366526-1-300x274.png 300w\" sizes=\"auto, (max-width: 547px) 100vw, 547px\" \/>                    <\/div>\n                                                    <div class=\"desc\"><p><strong>Linie de raportare 24\/7 pentru reac\u021bii adverse<\/strong><\/p>\n<p>Dita Estfarm pune la dispozi\u021bie o <strong>linie telefonic\u0103 dedicat\u0103, disponibil\u0103 24\/7<\/strong>, pentru raportarea reac\u021biilor adverse la <strong>medicamente, suplimente alimentare, produse cosmetice \u0219i dispozitive medicale<\/strong>.<\/p>\n<p>\ud83d\udcde <strong>Telefon (24\/7):<\/strong> +373 22 52 74 74<br \/>\n\ud83d\udce9 <strong>E-mail:<\/strong> <a rel=\"noopener\">farmacovigilenta@dita.md<\/a><\/p>\n<p>Ne asigur\u0103m c\u0103 toate sesiz\u0103rile sunt gestionate prompt, contribuind la siguran\u021ba \u0219i eficacitatea produselor utilizate.<\/p>\n<\/div>\n                                                    <b class='list-title'>Serviciile FV sunt furnizate includ:<\/b>\n                                <ul class='ordered-list'>\n                                            <li>Colectarea, traducerea (dac\u0103 este necesar) \u0219i transmiterea c\u0103tre Partener a tuturor evenimentelor adverse (EA) \u0219i\/sau reac\u021biilor adverse (RA), cazurilor speciale legate de administrarea medicamentelor, \u00eenregistrate pe teritoriul Republicii Moldova \u0219i ac\u021biunile ulterioare (dac\u0103 este cazul).<\/li>\n                                            <li>Asistarea \u00een cooperarea cu Autoritatea de Reglementare (primirea solicit\u0103rilor, scrisorilor, notific\u0103rilor, traducerea (dac\u0103 este necesar) \u0219i transmiterea acestora c\u0103tre Partener.<\/li>\n                                            <li>Asigurarea disponibilit\u0103\u021bii 24\/7 a sistemului de FV.<\/li>\n                                            <li>Prezentarea rapoartelor consolidate (Rapoarte periodice actualizate privind siguran\u021ba, Planurile de gestionare a riscurilor etc.) c\u0103tre Autoritatea de Reglementare, asigur\u00e2nd confirmarea depunerii.<\/li>\n                                            <li>Transmiterea CIOMS c\u0103tre Autoritatea de Reglementare \u0219i asigurarea confirm\u0103rii expedierii.<\/li>\n                                            <li>Furnizarea de informa\u021bii privind legisla\u021bia local\u0103 \u0219i modific\u0103rile acesteia \u00een domeniul farmacovigilen\u021bei.<\/li>\n                                            <li>Asistarea \u0219i suportul \u00een procedura de reconciliere \u00eentre Partener \u0219i Autoritatea de Reglementare.<\/li>\n                                            <li>Servicii de consultan\u021b\u0103.<\/li>\n                                            <li>Depunerea pentru aprobare la Autoritatea de Reglementare a materialelor educa\u021bionale \u0219i DHPC.<\/li>\n                                            <li>Monitorizarea literaturii locale de specialitate pentru a identifica informa\u021bii privind siguran\u021ba \u0219i eficacitatea produselor Partenerului.<\/li>\n                                    <\/ul>   \n            <\/div>                            \n        <\/div>\n    <\/section>\n    \n\n            <section class='page-section'>\n            <div class=\"wrap\">\n                <div class=\"section-top-box\">\n                                            <h2 class='big-bg'>Angajamentul nostru pentru excelen\u021b\u0103 \u0219i responsabilitate define\u0219te fiecare pas pe care \u00eel facem, pentru o comunitate mai s\u0103n\u0103toas\u0103 \u0219i un viitor mai bun.<\/h2>\n                                                                                        <a target=\"_blank\" href=\"http:\/\/dita.md\/contacte\/\" class=\"btn blue\">\n                            Contacteaz\u0103-ne                        <\/a>\n                                    <\/div>                     \n            <\/div>\n        <\/section>\n    ","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1836","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharmacovigilance - Dita Estfarm<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dita.md\/en\/pharmacovigilance\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmacovigilance - Dita Estfarm\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dita.md\/en\/pharmacovigilance\/\" \/>\n<meta property=\"og:site_name\" content=\"Dita Estfarm\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-24T15:54:52+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/dita.md\/en\/pharmacovigilance\/\",\"url\":\"https:\/\/dita.md\/en\/pharmacovigilance\/\",\"name\":\"Pharmacovigilance - Dita Estfarm\",\"isPartOf\":{\"@id\":\"https:\/\/dita.md\/en\/#website\"},\"datePublished\":\"2025-02-17T09:00:15+00:00\",\"dateModified\":\"2025-02-24T15:54:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/dita.md\/en\/pharmacovigilance\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/dita.md\/en\/pharmacovigilance\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/dita.md\/en\/pharmacovigilance\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Prima pagin\u0103\",\"item\":\"https:\/\/dita.md\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharmacovigilance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/dita.md\/en\/#website\",\"url\":\"https:\/\/dita.md\/en\/\",\"name\":\"Dita Estfarm\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/dita.md\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharmacovigilance - Dita Estfarm","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dita.md\/en\/pharmacovigilance\/","og_locale":"en_US","og_type":"article","og_title":"Pharmacovigilance - Dita Estfarm","og_url":"https:\/\/dita.md\/en\/pharmacovigilance\/","og_site_name":"Dita Estfarm","article_modified_time":"2025-02-24T15:54:52+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/dita.md\/en\/pharmacovigilance\/","url":"https:\/\/dita.md\/en\/pharmacovigilance\/","name":"Pharmacovigilance - Dita Estfarm","isPartOf":{"@id":"https:\/\/dita.md\/en\/#website"},"datePublished":"2025-02-17T09:00:15+00:00","dateModified":"2025-02-24T15:54:52+00:00","breadcrumb":{"@id":"https:\/\/dita.md\/en\/pharmacovigilance\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dita.md\/en\/pharmacovigilance\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/dita.md\/en\/pharmacovigilance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Prima pagin\u0103","item":"https:\/\/dita.md\/en\/"},{"@type":"ListItem","position":2,"name":"Pharmacovigilance"}]},{"@type":"WebSite","@id":"https:\/\/dita.md\/en\/#website","url":"https:\/\/dita.md\/en\/","name":"Dita Estfarm","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dita.md\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/dita.md\/en\/wp-json\/wp\/v2\/pages\/1836","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dita.md\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/dita.md\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/dita.md\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/dita.md\/en\/wp-json\/wp\/v2\/comments?post=1836"}],"version-history":[{"count":1,"href":"https:\/\/dita.md\/en\/wp-json\/wp\/v2\/pages\/1836\/revisions"}],"predecessor-version":[{"id":1839,"href":"https:\/\/dita.md\/en\/wp-json\/wp\/v2\/pages\/1836\/revisions\/1839"}],"wp:attachment":[{"href":"https:\/\/dita.md\/en\/wp-json\/wp\/v2\/media?parent=1836"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}